Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 21, 2005

In Re: Pfizer Inc. Securities, Derivative & ERISA Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 26, 2015

    2nd Circ. Asks How Expert Report Could Derail Pfizer Action

    A Second Circuit panel wondered Tuesday how an extensively briefed securities fraud class action alleging Pfizer Inc. hid deadly risks associated with two painkillers could have been tossed on the eve of trial because of concerns over an economist's damages calculations, with two judges asking if less drastic measures would have sufficed.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login